Scott M Coiante Aprea Therapeutics, Inc. (APRE) insider trading activity

Scott M Coiante is SVP, Chief Financial Officer of Aprea Therapeutics, Inc.. Currently has a direct ownership of 145,065 shares of APRE, which is worth approximately $594,766. The most recent transaction as insider was on Jul 28, 2022, when has been sold 60,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 145K

0% 3M change

0% 12M change

Total Value Held $594,766

Scott M Coiante Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 28 2022	BUY Grant, award, or other acquisition	-	60,800 Added 29.53%	145,065 Common Stock
Jun 03 2022	SELL Payment of exercise price or tax liability	$28,227 $0.8 p/Share	35,284 Reduced 29.51%	84,265 Common Stock
Mar 10 2022	BUY Grant, award, or other acquisition	-	42,900 Added 26.41%	119,549 Common Stock
Feb 25 2022	SELL Payment of exercise price or tax liability	$25,782 $1.74 p/Share	14,817 Reduced 16.2%	76,649 Common Stock
Aug 25 2021	SELL Payment of exercise price or tax liability	$29,985 $3.98 p/Share	7,534 Reduced 7.61%	91,466 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	96,500 Added 49.36%	99,000 Common Stock

Also insider at

AGRX

AGILE THERAPEUTICS INC Healthcare

Chief Financial Officer

SMC

Scott M Coiante

SVP, Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Value

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aprea Therapeutics, Inc.

Track Activities on APRE

Account